Newsletter | July 11, 2025

07.11.25 -- BIO2025: Sanofi R&D, FDA's Martin Makary, Paying For New Therapies

SPONSOR

 

 

Revolutionize your approach to clinical trials at DPHARM: Disruptive Innovations to Modernize Clinical Research, taking place September 16–17, 2025, in Philadelphia. This conference showcases cutting-edge strategies and technologies designed to reduce patient and site burden, streamline operations, improve data quality, and accelerate access to therapies. Use code LSL20 for 20% off your registration.

FROM THE EDITOR

BIO2025: Sanofi R&D, FDA's Martin Makary, Paying For New Therapies

BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I attended.

 

INDUSTRY INSIGHTS

 

Validating Generative AI: A Framework For Reliability And Compliance

With structured CSA-driven validation and expert guidance, organizations can harness generative AI’s advantages safely and effectively, ensuring accuracy, compliance, and operational excellence.

 

Your Benefits to Working With A Clinical Research Marketing Agency

Distinguish your clinical trial through partnering with a clinical research marketing agency to effectively attract and retain eligible participant with customized campaigns and digital marketing.

 

Why ePROs In Oncology Are Perfect For Capturing The Patient's Voice

Recently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.

 

Viral Vector Producer Cell Lines: Learning From mAbs

Learn how applying bioprocessing knowledge from the production of mAbs can accelerate the development of viral vector cell lines and improve efficiency in gene therapy manufacturing.

 

Modular Facilities With Smaller Footprint Through Dynamic Perfusion

A CDMO wanted to establish a multi-modality facility while achieving around 300 kg/year throughput. At the same time, they had the desire to decrease upfront capital investment.

 

Nurturing The Next Generation Of Life Science Innovators

Middlesex County, NJ, offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.